Citadel Advisors’s DIPLOMAT PHARMACY, INC. DPLO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-37,600
| Closed | -$150K | – | 10575 |
|
|
2019
Q4 | $150K | Buy |
+37,600
| New | +$177K | ﹤0.01% | 8367 |
|
|
2019
Q3 | – | Sell |
-27,600
| Closed | -$168K | – | 10094 |
|
|
2019
Q2 | $168K | Sell |
27,600
-86,900
| -76% | -$462K | ﹤0.01% | 8304 |
|
|
2019
Q1 | $665K | Buy |
114,500
+84,500
| +282% | +$873K | ﹤0.01% | 6305 |
|
|
2018
Q4 | $404K | Buy |
30,000
+12,400
| +70% | +$209K | ﹤0.01% | 6748 |
|
|
2018
Q3 | $342K | Buy |
17,600
+9,300
| +112% | +$198K | ﹤0.01% | 7364 |
|
|
2018
Q2 | $212K | Sell |
8,300
-2,400
| -22% | -$56K | ﹤0.01% | 7801 |
|
|
2018
Q1 | $216K | Buy |
10,700
+500
| +5% | +$11.7K | ﹤0.01% | 7243 |
|
|
2017
Q4 | $205K | Sell |
10,200
-2,600
| -20% | -$51.1K | ﹤0.01% | 7083 |
|
|
2017
Q3 | $265K | Buy |
12,800
+1,100
| +9% | +$18.6K | ﹤0.01% | 6260 |
|
|
2017
Q2 | $173K | Buy |
+11,700
| New | +$195K | ﹤0.01% | 6651 |
|
|
2017
Q1 | – | Sell |
-10,200
| Closed | -$129K | – | 8311 |
|
|
2016
Q4 | $129K | Buy |
+10,200
| New | +$190K | ﹤0.01% | 6576 |
|
|
2016
Q3 | – | Sell |
-13,100
| Closed | -$459K | – | 8031 |
|
|
2016
Q2 | $459K | Sell |
13,100
-13,600
| -51% | -$428K | ﹤0.01% | 4609 |
|
|
2016
Q1 | $732K | Sell |
26,700
-10,000
| -27% | -$294K | ﹤0.01% | 3870 |
|
|
2015
Q4 | $1.26M | Buy |
36,700
+21,900
| +148% | +$683K | ﹤0.01% | 3298 |
|
|
2015
Q3 | $425K | Buy |
14,800
+2,600
| +21% | +$111K | ﹤0.01% | 5030 |
|
|
2015
Q2 | $546K | Sell |
12,200
-2,200
| -15% | -$82.8K | ﹤0.01% | 4818 |
|
|
2015
Q1 | $498K | Buy |
+14,400
| New | +$392K | ﹤0.01% | 4918 |
|
Other funds holding DPLO
Citadel Advisors's DPLO Position: Q1 2020 in Review
Citadel Advisors sold out of DIPLOMAT PHARMACY, INC. (DPLO) in Q1 2020, closing a stake of 20,463 shares — an estimated $82K sold.
Citadel Advisors first reported a position in DPLO in Q1 2015 and held it in 16 quarters. The position peaked at $27.5M in Q1 2017. 1 fund tracked by Wall St. Rank holds DPLO as of Q1 2020.
- Citadel Advisors reported no remaining DIPLOMAT PHARMACY, INC. position as of Q1 2020 after selling out during the quarter.
- Citadel Advisors sold 20,463 DIPLOMAT PHARMACY, INC. shares in Q1 2020, an estimated $82K.
- Citadel Advisors first reported a position in DIPLOMAT PHARMACY, INC. in Q1 2015 and held it in 16 quarters.
- Citadel Advisors's DIPLOMAT PHARMACY, INC. position peaked at $27.5M in Q1 2017.
- 1 fund tracked by Wall St. Rank held DIPLOMAT PHARMACY, INC. as of Q1 2020.
Based on Citadel Advisors's 13F filing for Q1 2020, filed 15 May 2020.